Literature DB >> 3026955

Noncytocidal mechanisms of action of tumor necrosis factor-alpha on human tumor cells: enhancement of HLA gene expression synergistic with interferon-gamma.

P Scheurich, M Krönke, C Schlüter, U Ucer, K Pfizenmaier.   

Abstract

In this report, we present evidence that tumor necrosis factor alpha (TNF-alpha) exerts regulatory activity on the expression of HLA genes in human tumor cell lines at the level of mRNA expression and at a posttranscriptional level. These mechanisms are independent of direct cytotoxic/cytostatic effects, as enhancement of HLA antigen expression was observed in both sensitive cell lines and in cell lines resistant to TNF-mediated growth inhibition. In a priori HLA-negative cells, a strong TNF-alpha-mediated enhancement of the Interferon gamma (IFN-gamma) induced expression of HLA genes was revealed by Northern blot and immunofluorescence analysis. A distinct mechanism of TNF-alpha action is suggested from enhancement of constitutively expressed HLA genes. In this case, TNF-alpha raised HLA antigen density without apparent enhancement of cytoplasmic mRNA levels. This indicates that TNF-alpha influences HLA expression also at the level of translation or at a posttranslational level. TNF-alpha treatment of HLA-negative cells did not by itself result in HLA gene induction, suggesting that TNF-alpha acts as an enhancer and not as an inducer of HLA gene expression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026955     DOI: 10.1016/s0171-2985(86)80111-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.

Authors:  S Stemme; G Fager; G K Hansson
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

Review 2.  Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition.

Authors:  K Pfizenmaier; M Krönke; P Scheurich; G A Nagel
Journal:  Blut       Date:  1987-07

3.  Cytostasis of different tumours by a murine PPD-reactive CD4+ T lymphocyte clone is mediated by interferon-gamma and tumour necrosis factor alone or synergistically.

Authors:  M G Wing; A M Montgomery; C Harley; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses.

Authors:  B Thoma; M Grell; K Pfizenmaier; P Scheurich
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

Review 5.  CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis.

Authors:  Korey R Demers; Morgan A Reuter; Michael R Betts
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

6.  Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators.

Authors:  R Unglaub; B Maxeiner; B Thoma; K Pfizenmaier; P Scheurich
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

7.  Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.

Authors:  J S Weber; G Jay; K Tanaka; S A Rosenberg
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.